March 24, 2026

GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

Conexiant

March 23, 2026

Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

Conexiant

March 23, 2026

The Lipitor Warning for GLP-1 Drugmakers

Pfizer’s Lipitor experience shows the structural risks that today’s GLP-1 innovators may soon face

The Medicine Maker

March 20, 2026

Obesity Care Lags Behind Advances in Treatment

A 2026 expert perspective highlights system-level gaps in care delivery

Conexiant

March 18, 2026

Adjusted Calcium Is Lying — And Labs Keep Printing It

Choy et al. argue it's time to stop trusting a number that's been unreliable for fifty years.

Conexiant

March 12, 2026

Precision Therapies: The Last Mile

Why therapies still take years to reach the patients who need them

The Medicine Maker

March 11, 2026

Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer

Discover how the early management of malnutrition and hydration in pancreatic cancer patients can enhance treatment outcomes and overall quality of life.

JADPRO

March 05, 2026

ADA joins coalition urging Education Department to adjust timeline for student loan changes

The ADA is urging the Education Department to adjust the implementation timeline for student loan changes that could affect dental students.

ADA News

March 05, 2026

Medical Societies and More Respond to HHS RFI on AI Use in Clinical Care

In time for the assigned deadline of February 23, 2026, medical societies, companies, health-care systems, and more have responded to a request for information from the Department of Health and Human ...

The ASCO Post

March 05, 2026

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

Conexiant